Sjur Humerfelt

1.2k total citations
27 papers, 788 citations indexed

About

Sjur Humerfelt is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sjur Humerfelt has authored 27 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sjur Humerfelt's work include Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Air Quality and Health Impacts (5 papers). Sjur Humerfelt is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Air Quality and Health Impacts (5 papers). Sjur Humerfelt collaborates with scholars based in Norway, United States and Denmark. Sjur Humerfelt's co-authors include Amund Gulsvik, Ingunn Skjørten, Kjetil Steine, V. H. Hansteen, Janne Mykland Hilde, Morten Nissen Melsom, Jonny Hisdal, Gunnar Kvåle, Ole Jørgen Grøtta and G E Eide and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Sjur Humerfelt

27 papers receiving 766 citations

Peers

Sjur Humerfelt
Wisia Wedzicha United Kingdom
Diane P. Holst Australia
Hana Muellerova United Kingdom
Swetlana Gaffron Netherlands
Alexander Arynchyn United States
Spyridon Fortis United States
DS Postma United States
Sjur Humerfelt
Citations per year, relative to Sjur Humerfelt Sjur Humerfelt (= 1×) peers Robab Kohansal

Countries citing papers authored by Sjur Humerfelt

Since Specialization
Citations

This map shows the geographic impact of Sjur Humerfelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sjur Humerfelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sjur Humerfelt more than expected).

Fields of papers citing papers by Sjur Humerfelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sjur Humerfelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sjur Humerfelt. The network helps show where Sjur Humerfelt may publish in the future.

Co-authorship network of co-authors of Sjur Humerfelt

This figure shows the co-authorship network connecting the top 25 collaborators of Sjur Humerfelt. A scholar is included among the top collaborators of Sjur Humerfelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sjur Humerfelt. Sjur Humerfelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilde, Janne Mykland, Jonny Hisdal, Ingunn Skjørten, et al.. (2020). Left ventricular dysfunction in COPD without pulmonary hypertension. PLoS ONE. 15(7). e0235075–e0235075. 1 indexed citations
2.
Skjørten, Ingunn, Janne Mykland Hilde, Morten Nissen Melsom, et al.. (2018). Exercise capacity in COPD patients with exercise-induced pulmonary hypertension. International Journal of COPD. Volume 13. 3599–3610. 7 indexed citations
3.
Skjørten, Ingunn, et al.. (2017). Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD. SHILAP Revista de lepidopterología. 5 indexed citations
4.
Skjørten, Ingunn, Janne Mykland Hilde, Morten Nissen Melsom, et al.. (2017). Cardiopulmonary exercise test and PaO<sub>2</sub> in evaluation of pulmonary hypertension in COPD. International Journal of COPD. Volume 13. 91–100. 13 indexed citations
5.
Gulsvik, A, et al.. (2014). Validity of the European short list of respiratory diseases: a 40-year autopsy study. European Respiratory Journal. 45(4). 953–961. 4 indexed citations
6.
Wang, Ying, et al.. (2014). Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). International Journal of COPD. 9. 99–99. 85 indexed citations
7.
Hewitt, Stephen, Sjur Humerfelt, Torgeir T. Søvik, et al.. (2014). Long-Term Improvements in Pulmonary Function 5 Years After Bariatric Surgery. Obesity Surgery. 24(5). 705–711. 39 indexed citations
8.
Hilde, Janne Mykland, Ingunn Skjørten, Ole Jørgen Grøtta, et al.. (2013). Right Ventricular Dysfunction and Remodeling in Chronic Obstructive Pulmonary Disease Without Pulmonary Hypertension. Journal of the American College of Cardiology. 62(12). 1103–1111. 144 indexed citations
9.
Skjørten, Ingunn, Janne Mykland Hilde, Morten Nissen Melsom, et al.. (2013). Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease. Respiratory Medicine. 107(8). 1271–1279. 20 indexed citations
10.
Hilde, Janne Mykland, Ingunn Skjørten, V. H. Hansteen, et al.. (2012). Haemodynamic responses to exercise in patients with COPD. European Respiratory Journal. 41(5). 1031–1041. 82 indexed citations
11.
Gulsvik, A, Amund Gulsvik, Eva Skovlund, et al.. (2012). The association between lung function and fatal stroke in a community followed for 4 decades. Journal of Epidemiology & Community Health. 66(11). 1030–1036. 25 indexed citations
12.
Steine, Kjetil, et al.. (2007). Rheumatic mitral valve stenosis mimicking advanced lung cancer. Heart and Vessels. 22(5). 345–348. 1 indexed citations
13.
Lehmann, Sverre, Per Bakke, Geir Egil Eide, Sjur Humerfelt, & Amund Gulsvik. (2005). Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a β2-agonist. Pulmonary Pharmacology & Therapeutics. 19(4). 272–280. 21 indexed citations
14.
Humerfelt, Sjur, et al.. (2004). [Clinical pharmacist improves the use of drugs in hospital].. PubMed. 124(15). 1923–5. 2 indexed citations
15.
Gulsvik, Amund, Laurel Beckett, Per Bakke, et al.. (2001). Standardized submaximal exercise testing in never smokers: a normative study. Clinical Physiology. 21(5). 629–636. 5 indexed citations
16.
Gulsvik, Amund, Tor D. Tosteson, P Bakke, et al.. (2001). Expiratory and inspiratory forced vital capacity and one‐second forced volume in asymptomatic never‐smokers in Norway. Clinical Physiology. 21(6). 648–660. 68 indexed citations
17.
Humerfelt, Sjur, Geir Egil Eide, Gunnar Kvåle, & Amund Gulsvik. (1998). Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) variability in asymptomatic never‐smoking men. Clinical Physiology. 18(4). 387–396. 13 indexed citations
18.
Humerfelt, Sjur, G E Eide, & Amund Gulsvik. (1998). Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years. Thorax. 53(8). 649–655. 36 indexed citations
19.
Humerfelt, Sjur, et al.. (1998). Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. European Respiratory Journal. 11(2). 284–290. 52 indexed citations
20.
Humerfelt, Sjur, et al.. (1993). Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community. European Respiratory Journal. 6(8). 1095–1103. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026